Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Methotrexate
•
General Rheumatology
Do you always get a baseline chest xray in patients who will be starting methotrexate?
Related Questions
What is the maximum dose of leucovorin that you use with methotrexate?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
How do you approach managing nausea and GI side effects when initiating methotrexate?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
How do you approach management of a patient with multiple lung nodules and low titer +CCP but no active joint symptoms suggestive of RA?
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
Do you have any experience with compounded iguratimod either as adjunctive therapy or monotherapy for rheumatoid arthritis, Sjogrens, or axial spondyloarthropathy?
Are you comfortable trying a different JAK inhibitor in patients with prior JAK inhibitor allergy?
Does the presence of calcified granulomas on chest imaging influence your choice of biologic for treatment of psoriatic arthritis (or rheumatoid arthritis)?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
